Patients with thoracic malignancies invading the superior vena cava （SVC） and innominate vein that cause venous flow obstruction have a poor quality of lite and short survival time. Dartevelle et al reported that th...Patients with thoracic malignancies invading the superior vena cava （SVC） and innominate vein that cause venous flow obstruction have a poor quality of lite and short survival time. Dartevelle et al reported that the 3-year survival rates were 27% for patients with mediastinal malignancies and non-small cell lung cancer. Recently, some surgeons＇ experience suggested that the results of extensive resection and reconstruction of the SVC and innominate vein were excellent. From May 2003 to December 2005, radical resection and reconstruction of the SVC and/or innominate vein were performed in a group of patients for mediastinal or lung tumors invading the superior vena cava and/or innominate vein. We reported our experience in this retrospective study to explore the operative method, the optimal vascular graft, and the benefits of extended resection and reconstruction of SVC and/or innominate vein for invasive thoracic tumors.展开更多
文摘Patients with thoracic malignancies invading the superior vena cava （SVC） and innominate vein that cause venous flow obstruction have a poor quality of lite and short survival time. Dartevelle et al reported that the 3-year survival rates were 27% for patients with mediastinal malignancies and non-small cell lung cancer. Recently, some surgeons＇ experience suggested that the results of extensive resection and reconstruction of the SVC and innominate vein were excellent. From May 2003 to December 2005, radical resection and reconstruction of the SVC and/or innominate vein were performed in a group of patients for mediastinal or lung tumors invading the superior vena cava and/or innominate vein. We reported our experience in this retrospective study to explore the operative method, the optimal vascular graft, and the benefits of extended resection and reconstruction of SVC and/or innominate vein for invasive thoracic tumors.
